Development and Analytical Validation of a Reverse Transcription Droplet Digital PCR (RT-ddPCR) Assay for PD-L1 Transcripts in Circulating Tumor Cells.
BACKGROUND: PD-L1, an immune checkpoint protein, is an important biomarker for monitoring cancer patients during the administration of cancer immunotherapy. Droplet digital PCR (ddPCR), is a highly sensitive and accurate tool for the quantification of cancer biomarkers in liquid biopsy. We report th...
| Published in: | Clinical Chemistry Vol. 67; no. 4; pp. 642 - 653 |
|---|---|
| Main Authors: | , , , , , |
| Format: | Journal Article |
| Published: |
Oxford University Press / USA
Apr2021
|
| Online Access: | View this record in EBSCOhost |